CME Group Inc. (NASDAQ:CME – Get Rating) – Investment analysts at Jefferies Financial Group increased their Q2 2022 earnings per share estimates for CME Group in a report released on Tuesday, May 31st. Jefferies Financial Group analyst D. Fannon now expects that the financial services provider will earn $1.87 per share for the quarter, up from their previous estimate of $1.85. Jefferies Financial Group currently has a “Buy” rating and a $267.00 target price on the stock. Jefferies Financial Group also issued estimates for CME Group’s Q3 2022 earnings at $1.79 EPS, FY2022 earnings at $7.63 EPS, Q1 2023 earnings at $2.19 EPS, Q2 2023 earnings at $2.05 EPS, Q3 2023 earnings at $1.96 EPS, Q4 2023 earnings at $2.04 EPS and FY2023 earnings at $8.25 EPS.
A number of other brokerages have also recently commented on CME. Argus upgraded CME Group from a “hold” rating to a “buy” rating in a research note on Monday, May 16th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of CME Group from $262.00 to $210.00 in a research note on Thursday, May 19th. Citigroup lifted their price objective on CME Group from $275.00 to $280.00 in a report on Thursday, April 28th. Raymond James upped their price target on shares of CME Group from $240.00 to $265.00 and gave the company an “outperform” rating in a report on Thursday, February 10th. Finally, Compass Point upped their target price on shares of CME Group from $235.00 to $250.00 and gave the company a “neutral” rating in a research note on Thursday, February 10th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $248.47.
NASDAQ:CME opened at $199.37 on Thursday. The firm’s fifty day simple moving average is $220.30 and its 200 day simple moving average is $227.40. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group has a twelve month low of $185.79 and a twelve month high of $256.94. The firm has a market capitalization of $71.66 billion, a price-to-earnings ratio of 26.03, a PEG ratio of 4.12 and a beta of 0.48.
CME Group (NASDAQ:CME – Get Rating) last released its quarterly earnings data on Wednesday, April 27th. The financial services provider reported $2.11 earnings per share for the quarter, beating the consensus estimate of $2.00 by $0.11. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. CME Group had a return on equity of 9.29% and a net margin of 57.98%. The company’s revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.79 EPS.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 27th. Stockholders of record on Friday, June 10th will be paid a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.01%. The ex-dividend date is Thursday, June 9th. CME Group’s dividend payout ratio is presently 52.22%.
In other news, insider Sean Tully sold 3,000 shares of the firm’s stock in a transaction dated Friday, March 11th. The shares were sold at an average price of $229.00, for a total transaction of $687,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.30% of the company’s stock.
Several institutional investors and hedge funds have recently made changes to their positions in CME. Norges Bank purchased a new position in shares of CME Group during the fourth quarter valued at $750,203,000. Capital International Investors grew its stake in CME Group by 26.9% during the 4th quarter. Capital International Investors now owns 13,188,121 shares of the financial services provider’s stock valued at $3,013,006,000 after acquiring an additional 2,795,636 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in shares of CME Group by 132.0% in the first quarter. Massachusetts Financial Services Co. MA now owns 3,382,773 shares of the financial services provider’s stock worth $804,626,000 after purchasing an additional 1,924,772 shares in the last quarter. Parnassus Investments LLC boosted its holdings in shares of CME Group by 15.5% during the third quarter. Parnassus Investments LLC now owns 7,097,398 shares of the financial services provider’s stock worth $1,372,495,000 after purchasing an additional 951,681 shares during the period. Finally, TD Asset Management Inc. grew its holdings in shares of CME Group by 224.1% during the 1st quarter. TD Asset Management Inc. now owns 992,012 shares of the financial services provider’s stock valued at $235,960,000 after acquiring an additional 685,884 shares in the last quarter. Institutional investors own 86.71% of the company’s stock.
About CME Group (Get Rating)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.
Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.